News from anthera pharmaceuticals A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Apr 05, 2013, 17:45 ET

Anthera Refinances Existing Debt with New $20 Million Credit Facility and Secures $18.5 Million Committed Equity Financing Facility

Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH), a biopharmaceutical company developing drugs to treat serious diseases associated with inflammation,...

Mar 27, 2013, 16:15 ET

Anthera Initiates CHABLIS-SC1 Phase 3 Clinical Study in Lupus with Blisibimod

Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH), a biopharmaceutical company developing drugs to treat serious diseases associated with inflammation...

Mar 26, 2013, 16:15 ET

Anthera Pharmaceuticals Reports 2012 Fourth Quarter And Fiscal Year Financial Results

 Anthera Pharmaceuticals, Inc. (NASDAQ: ANTH), today announced financial results and business highlights for the quarter and fiscal year ended...

Mar 22, 2013, 08:00 ET

Anthera Announces Data from the Phase 2b PEARL-SC Study Will Be Presented at the 10th International Congress on Systemic Lupus Erythematosus

 Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH), a biopharmaceutical company developing drugs to treat serious diseases associated with...

Feb 07, 2013, 17:29 ET

Anthera Pharmaceuticals to Present at the 2013 Leerink Global Healthcare Conference

 Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH) a biopharmaceutical company developing drugs to treat serious diseases associated with...

Feb 05, 2013, 08:30 ET

Anthera Pharmaceuticals Announces Departure of Georgina Kilfoil

 Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH) today announced that Senior Vice President of Product Development Georgina Kilfoil has...

Jan 30, 2013, 09:48 ET

Anthera Pharmaceuticals Announces Completion of Public Offering of Common Stock

 Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH) today announced that it has completed the previously announced underwritten public offering...

Jan 25, 2013, 08:57 ET

Anthera Pharmaceuticals Announces Pricing of Public Offering of Common Stock

 Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH) today announced the pricing of an underwritten public offering of 60,606,061 shares of its...

Jan 24, 2013, 16:01 ET

Anthera Pharmaceuticals Announces Proposed Public Offering of Common Stock

 Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH) today announced that it intends to offer and sell shares of its common stock in an underwritten...

Nov 28, 2012, 08:00 ET

Anthera Announces Data from the Phase 2b PEARL-SC Study Presented at the 2012 Asian Lupus Summit

 Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH), a biopharmaceutical company developing drugs to treat serious diseases associated with...

Nov 20, 2012, 17:00 ET

Anthera Pharmaceuticals to Present at the Piper Jaffray Health Care Conference

Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH), a biopharmaceutical company developing drugs to treat serious diseases associated with inflammation...

Nov 13, 2012, 17:17 ET

Anthera Announces Additional Data from the Phase 2b PEARL-SC Presented at the ACR/ARHP 2012 Annual Scientific Meeting

Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH), a biopharmaceutical company developing drugs to treat serious diseases associated with inflammation...

Nov 01, 2012, 08:00 ET

Anthera Announces the Phase 2b PEARL-SC Data Has Been Accepted as a Late Breaking Poster Presentation at the ACR/ARHP 2012 Annual Scientific Meeting

 Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH), a biopharmaceutical company developing drugs to treat serious diseases associated with...

Oct 24, 2012, 17:00 ET

Anthera Pharmaceuticals Reports 2012 Third Quarter Financial Results And Provides Clinical Progress Update

Anthera Pharmaceuticals, Inc. (NASDAQ: ANTH), today announced financial results and business highlights for the quarter ended September 30, 2012....

Oct 18, 2012, 17:00 ET

Anthera Announces Third Quarter 2012 Financial Report and Conference Call

Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH), a biopharmaceutical company developing drugs to treat serious diseases associated with inflammation...

Sep 17, 2012, 08:00 ET

Anthera Announces the Advancement of Blisibimod into Phase 3 Development for Patients with Systemic Lupus Erythematosus (SLE)

Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH), a biopharmaceutical company developing drugs to treat serious diseases associated with inflammation...

Aug 07, 2012, 16:15 ET

Anthera Pharmaceuticals Reports 2012 Second Quarter Financial Results And Provides Clinical Progress Update

Anthera Pharmaceuticals, Inc. (NASDAQ: ANTH), today announced financial results and business highlights for the quarter ended June 30, 2012....

Aug 01, 2012, 14:00 ET

Anthera to Report Second Quarter 2012 Financial Results

 Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH), a biopharmaceutical company developing drugs to treat serious diseases associated with...

Jul 24, 2012, 16:15 ET

Anthera Pharmaceuticals Announces Exercise in Full of Over-Allotment Option and Completion of Public Offering of Common Stock

 Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH), today announced that it has completed the previously announced underwritten public offering of...

Jul 19, 2012, 09:16 ET

Anthera Pharmaceuticals Announces Pricing of Public Offering of Common Stock

 Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH) today announced the pricing of an underwritten public offering of 33 million shares of its...